Interventional Programs' Impact on Patients' Quality of Life and Functioning
Sponsored by Psychiatric Hospital of the Cross
About this trial
Last updated 6 months ago
Study ID
HPC 001-08-2024
Status
Active, not recruiting
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18 to 65 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 6 months ago
What is this trial about?
The objective of the study is to investigate the effect of interventional program in
improving the quality of life for individuals with chronic schizophrenia The design of
the study will be an interventional study - Randomized Control Trial - taking place in
the Psychiatric hospital of the Cross Lebanon. Six types of intervention will be done on
the patients such as ping-pong, sport exercise, psychoeducation program, nutrition, art
therapy and bibliotherapy. A 100 patients adhering to the inclusion and exclusion
criteria will be randomized into two groups (50 patients in the intervention group and 50
patients in the control group) - Simple Randomization. A Baseline and follow-up
assessments will take place at the beginning of the study and after three months through
using Arabic Validated Scales. The scales that be used are the following Positive and
negative symptoms scale (PANSS), to determine severity of symptoms in patients. WHO
quality of life questionnaire WHOQOL- BREF Arabic version: physical, psychological,
social and environmental and EQ-5D scale, to determine quality of life of patients. MOCA
scale to determine cognitive function, Rosenberg self-esteem questionnaire, Social
functioning questionnaire QFS and Birchwood Insight Scale.
What are the participation requirements?
Inclusion Criteria
- Individuals diagnosed with chronic schizophrenia according to DSM-V criteria
- Aged 18-65.
- Physically capable of participating in physical
- Clinically stable
Exclusion Criteria
- Active substance use
- Severe cognitive impairment
- Intellectual disability